Verseon Corp (LSE:VSN) - Share price - Overview

Stock Report

Verseon Corp VSN

Last Price
GBX155.00

Day Change
-1.50|-0.96%

As of 17/02/2017
15:55:00 GMT | GBX
Minimum 15 Minutes Delay.

Last Close156.50p
Day Range153.00 - 157.00
Mkt Cap234.70Mil
52-Wk Range148.00 - 178.80
Yield %0.00
ISINUSU9221J1098
Volume17,816
P/E-39.67
P/SInfinity
P/CF-40.16

Share Price

Total Returns 17/02/2017

 Chg (%)  
More ...
Verseon Corp-1.59 
FTSE 100 TR GBP1.55
 
Financials
201320142015
More ...
Income Statement
Turnover0.100.000.00
Operating Profit-1.34-4.79-6.35
Net Profit-1.85-4.98-5.01
Reported EPS-1.20-3.04-3.91
Balance Sheet
Current Assets0.020.0350.52
Non Current Assets0.050.057.32
Total Assets0.070.0857.83
Current Liabilities2.831.581.23
Total Liabilities5.882.871.23
Total Equity-5.81-2.7956.60
Cash Flow
Operating Cash Flow-1.27-2.10-5.07
Net Change in Cash0.000.0027.18
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2016-13.57-8.42--18.42---
2017-17.29-11.35--13.65---
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
04/11/2016Transfer inDr. Thomas Hecht0.007,0090.00
19/09/2016PurchaseMs. Eniko Fodor161.006,0009,660.00
03/05/2016Transfer inDr. Thomas Hecht0.004,3250.00

Company Profile

Verseon Corp is a technology-based pharmaceutical company that employs its proprietary technology to design novel therapeutics for today's challenging diseases. It generates multiple, chemically-diverse drug candidates for each discovery programs.

Sector

Biotechnology

Market Position

651 of 1851 Companies

Index

Outlook

(05/09/2016) no outlook statement

Next Event 07/03/2017

Next annual report due
Ratios
CompSecMkt
More ...
PER (E)-13.6514.3016.11
Div Yld (E)0.003.764.04
PEG (E)0.00-0.601.59
ROCE-8.62202.24107.14
Op Mrgn0.00-12.26-17.07
EPS Grwth0.0040.8828.56
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy1
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanDr. Thomas Hecht
Chief Executive OfficerMr. Adityo Prakash
Chief Operating Officer, Chief FinancialMs. Eniko Fodor
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.